23 Jul, 2026
According to Straits Research, the global medical nutrition market size was valued at $53.8 billion in 2025 and is projected to grow from $57.49 billion in 2026 to $97.83 billion by 2034, growing at a CAGR of 6.87% during the forecast period 2026–2034.
The global medical nutrition market is witnessing robust growth, driven by a combination of key aspects. The surging incidence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases is generating a steady need for targeted nutritional solutions to support treatment and recovery processes. At the same time, the increasing global geriatric population is boosting demand for nutrition products that address age-related issues like frailty, muscle degeneration, and cognitive impairment.
Furthermore, the growing emphasis on preventive healthcare has raised awareness about the vital role of nutrition in promoting long-term wellness, leading to its integration into standard medical care. Advancements in clinical research and technology are also facilitating the development of tailored nutritional formulations designed to enhance patient outcomes and overall quality of life. Collectively, these trends are elevating medical nutrition from a supplementary therapy to a core element of modern healthcare, with widespread adoption across hospitals, home care services, and outpatient facilities worldwide.
The global challenge of hospital-related malnutrition is escalating, posing serious threats to patient recovery, prolonging hospital stays, and affecting treatment effectiveness. Malnutrition weakens the immune system, slows down wound healing, and heightens the risk of infections, especially in older adults and those with chronic illnesses. In response, hospitals are increasingly recognizing clinical nutrition as an essential component of patient care.
These concerning statistics depict the critical need for implementing standardized nutritional care practices across clinical environments.
Government-driven initiatives and awareness campaigns are instrumental in driving market growth, particularly in emerging economies. These efforts are designed to combat malnutrition, enhance healthcare outcomes, and support the adoption of therapeutic nutrition across various population groups. Increasingly, health ministries and international organizations are allocating resources toward preventive and clinical nutrition programs, thereby boosting the demand for specialized medical nutrition products.
Similar initiatives in countries such as India, Brazil, and Kenya have integrated free nutritional supplements into public health programs. These government-supported strategies create strong growth prospects for manufacturers to form partnerships and expand their presence in the global market.
The North American medical nutrition market is witnessing robust growth, driven by the region’s aging population, high prevalence of chronic illnesses, and advanced healthcare infrastructure. According to the CDC, over 60% of U.S. adults suffer from at least one chronic disease, increasing the demand for disease-specific nutritional therapies. The U.S. dominates the regional market due to strong insurance coverage for medical nutrition in hospitals and home care settings.
Additionally, Canada’s government-led nutritional interventions for seniors and patients with cancer and diabetes are boosting product uptake. The increasing popularity of home enteral nutrition (HEN) is another growth driver, with companies like Abbott and Nestlé expanding their HEN offerings. Furthermore, recent FDA approvals for novel formulations and clinical nutrition products are encouraging innovation and market expansion across hospitals, outpatient clinics, and e-pharmacies in the region.
sales@straitsresearch.com